JOURNAL OF BIOMATERIALS APPLICATIONS, published by SAGE PUBLICATIONS LTD, serves as a pivotal platform for the dissemination of cutting-edge research in the field of biomaterials and biomedical engineering. With an ISSN of 0885-3282 and an E-ISSN of 1530-8022, this journal has been a respected venue for scholarly communication since its inception in 1986. Aiming to provide comprehensive insights into the applications of biomaterials, this journal publishes high-quality articles that explore innovative materials and methodologies, thereby fostering advancements in medical technology and tissue engineering. The journal consistently ranks in the third quartile (Q3) for both Biomaterials and Biomedical Engineering categories, strengthening its position among the noteworthy academic resources available today. With a dedicated readership comprising researchers, industry professionals, and students, JOURNAL OF BIOMATERIALS APPLICATIONS plays a vital role in supporting knowledge exchange and scientific progress within these dynamic fields.

BIOMATERIALS, published by Elsevier Science Ltd, is a premier academic journal dedicated to the interdisciplinary field of biomaterials research. With an impressive impact factor, it ranks in the Q1 quartile across multiple categories including Bioengineering, Biomaterials, and Biophysics, showcasing its significance in advancing scientific knowledge. Established in 1980 and set to converge its discussions through 2025, this journal provides a critical platform for researchers and professionals to disseminate their findings on the development, application, and performance of biomaterials. The journal covers a wide range of topics, from the mechanics of materials to nanotechnology, and is highly regarded with top Scopus rankings in essential categories, including an exceptional position within the 99th percentile for Biophysics. Although not an open access journal, BIOMATERIALS remains vital for students and established researchers alike, ensuring accessibility to groundbreaking research in the field. Engage with cutting-edge studies that pave the way for innovative applications in medicine, engineering, and beyond.

The International Journal of Biomaterials, published by HINDAWI LTD, is a premier platform for disseminating groundbreaking research in the fields of biomaterials and biomedical engineering. With an Open Access approach since 2009, this journal provides unhindered access to innovative studies and applications aimed at advancing medical technologies and improving patient outcomes. Notably ranked in the Q3 category for both Biomaterials and Biomedical Engineering in 2023, it serves as an essential resource for researchers, practitioners, and students alike. The journal's Scopus rankings, including a 49th percentile in Biomedical Engineering and a 40th percentile in Biomaterials, further underscore its growing prominence in the academic community. With contributions spanning from 2011 to 2024, the journal seeks to foster collaborative research and promote developments that enhance the understanding and application of biomaterials in healthcare.

Acta Biomaterialia, published by Elsevier Science Ltd, is a leading journal in the fields of biochemistry, biomaterials, biomedical engineering, biotechnology, and molecular biology. With an ISSN of 1742-7061 and an E-ISSN of 1878-7568, this prestigious journal has secured a remarkable position in the academic community, evidenced by its inclusion in the Q1 category across multiple disciplines for 2023. It ranks impressively at #21 in biochemistry, #16 in biomedical engineering, #18 in biotechnology, and #11 in biomaterials, reflecting its high impact and relevance to ongoing research and development. The journal provides a platform for disseminating innovative research and advancements in the design and application of biomaterials, contributing to scientific discussions that propel the field forward. Although it does not currently offer open access options, Acta Biomaterialia continues to attract contributions that advance our understanding of biomaterials and their interactions with biological systems, ensuring that researchers, professionals, and students remain informed about the latest trends and breakthroughs in this rapidly evolving area of study.

Materials Today Bio, published by Elsevier, is an esteemed open-access journal dedicated to advancing the fields of bioengineering, biomaterials, and biomedical engineering. Since its inception in 2019, this journal has quickly made a name for itself, currently ranked Q1 in multiple categories including Bioengineering, Biomaterials, and Biotechnology, reflecting its exceptional quality and relevance in the rapidly evolving landscape of bio-related sciences. With an impressive Scopus ranking positioning it in the top 25% of its categories, Materials Today Bio provides a vital platform for researchers and professionals to share cutting-edge discoveries and innovative applications that bridge the gap between materials science and biological studies. Accessible to a global audience, this journal not only fosters collaboration among the scientific community but also aims to highlight significant advancements in cell and molecular biology, making it an indispensable resource for students and seasoned experts alike. The journal's commitment to open access since 2019 underscores its dedication to disseminating knowledge widely, ensuring that crucial findings reach those who can benefit from them the most.

Materials is an esteemed journal published by MDPI, dedicated to advancing the fields of Condensed Matter Physics and Materials Science. With its commitment to Open Access since its inception in 2008, the journal has made significant strides in disseminating high-quality research globally, allowing researchers, professionals, and students easy access to cutting-edge studies without financial barriers. Hailing from Switzerland, the journal has shown remarkable growth and prominence, currently ranked in the Q2 quartile in its categories according to the latest assessments, which highlights its impact within the community. As the journal converges its focus from 2008 to 2024, it aims to continually foster a robust exchange of knowledge on innovative materials and their applications, thereby supporting the evolving landscape of science and technology. With an E-ISSN of 1996-1944 and a user-friendly platform, Materials is poised to be a leading choice for scholars eager to contribute to and engage with pioneering research.

Biomaterials Research, published by the American Association for the Advancement of Science, is a prominent open access journal established in 2014, dedicated to advancing the field of biomaterials. Based in the United Kingdom, this journal has swiftly become an essential platform for researchers and practitioners, offering groundbreaking insights in biomaterials, biomedical engineering, ceramics and composites, and miscellaneous medical fields. With its impressive Q1 ranking across multiple relevant categories in 2023 and its strong Scopus rankings, including a remarkable 90th percentile in the medicine category, Biomaterials Research showcases high-quality, peer-reviewed research designed to address both practical and theoretical challenges in biomaterials science. As an open access journal, it promotes wider dissemination and accessibility of research findings, crucial for fostering innovation and collaboration within the scientific community. Researchers, professionals, and students alike are encouraged to contribute, read, and engage with the latest developments in this dynamic field.

Regenerative Biomaterials, published by Oxford University Press, serves as a premier platform for the dissemination of innovative research in the rapidly evolving field of biomaterials. Since its inception in 2014, this esteemed open-access journal has fostered a collaborative and diverse scientific community, providing free access to impactful articles that enhance our understanding of regenerative medicine and tissue engineering. With a commendable impact factor and ranking within the top quartiles of both Biomedical Engineering and Materials Science, it is recognized for its rigorous peer-review process and high-quality publications. The journal aims to bridge the gap between fundamental research and applied sciences, promoting advanced studies that contribute to clinical applications and regeneration strategies. Researchers, practitioners, and students alike are encouraged to engage with the journal’s content to foster interdisciplinary collaboration and drive future innovations in the biomaterials domain.

Materials Science & Engineering C-Materials for Biological Applications is a premier journal published by ELSEVIER, dedicated to advancing the field of biomaterials through interdisciplinary research. With a robust ISSN of 0928-4931, this journal has made its mark in the realms of Chemical Engineering and Materials Science, achieving impressive Scopus rankings within its categories, namely Rank #16/151 in Bioengineering (89th percentile) and Rank #13/112 in Biomaterials (88th percentile). Although the journal's coverage in Scopus has been discontinued since 2021, it remains a critical resource for researchers, professionals, and students eager to explore innovative materials and their applications in biological contexts. The journal’s open access policy enhances its accessibility, fostering a global exchange of knowledge and inspiring future advancements in the field of materials science.

Journal of Tissue Engineering and Regenerative Medicine, published by WILEY, stands as a pivotal platform in the fields of biomaterials, biomedical engineering, and regenerative medicine. With an ISSN of 1932-6254 and an E-ISSN of 1932-7005, this journal, based in the United Kingdom, has consistently delivered high-quality research since its inception in 2006, converging critical insights through 2024. With an impressive citation profile reflected in its Scopus rankings—specifically a rank of #58 in Medicine and #75 in Biomedical Engineering—the journal is acknowledged for its substantial impact, as demonstrated by its competitive quartile standings in 2023. Notably, it maintains a Q3 ranking in Biomaterials and Q2 in both Biomedical Engineering and Medicine (miscellaneous), showcasing its influence and relevance in the rapidly evolving interplay between engineering and medicine. The journal serves as a vital resource for researchers and practitioners aiming to stay abreast of innovations and breakthroughs in regenerative therapies, tissue scaffolds, and biomaterials. While not an open-access publication, it fosters academic dialogue and knowledge dissemination that is crucial for advancing the field.